Endoscopic ultrasound guided radiofrequency ablation, for pancreatic cystic neoplasms and neuroendocrine tumors
Abstract
EUS-RFA of pancreatic neoplasms with a novel monopolar RF probe was well tolerated in all cases. Our preliminary data suggest that the procedure is straightforward and safe. The response ranged from complete resolution to a 50% reduction in size.
Metrics
Citation History
Topics
Related Documents
Endoscopic ultrasound-guided radiofrequency ablation of premalignant pancreatic-cystic neoplasms and neuroendocrine tumors: prospective study
Fadi YounisDana Ben‐Ami ShorNir LubezkyRavit GevaEsther OsherOren ShiboletAdam PhillipsErez Scapa
Endoscopic ultrasound-guided radiofrequency ablation for pancreatic neuroendocrine tumors and pancreatic cystic neoplasms: a prospective multicenter study
Marc BarthetMarc GiovanniniNathalie LesavreChristian BoustièreBertrand NapoléonStéphane KochMohamed GasmiGeoffroy VanbiervlietJean‐Michel Gonzalez
Endoscopic ultrasound-guided radiofrequency ablation for pancreatic neuroendocrine tumor
351 Endoscopic Ultrasound Guided Radiofrequency Ablation (EUS-RFA) for Cystic Neoplasms and Neuroendocrine Tumors of the Pancreas
Madhava PaiHakan ŞentürkSundeep LakhtakiaD. Nageshwar ReddyVito R. CicinnatiIyad KabarSusanne BeckebaumZhendong JinDong WangJianfeng YangXiaofeng ZhangMichel KahalehNagy HabibWilliam R. Brugge
Endoscopic Ultrasound-Guided Radiofrequency Ablation: A New Therapeutic Approach for Pancreatic Neuroendocrine Tumors
Kira OleinikovAlain DancourJulia EpshteinAriel A. BensonHaggi MazehIlanit TalShay MatalonCarlos BenbassatDan M. LivovskyEran GoldinDavid J. GrossHarold JacobSimona Grozinsky‐Glasberg